Skip to main content
Equibles

Adam Morgan

Chairman

Heron Therapeutics, Inc. /De/ (HRTX)

Board Member

Heron Therapeutics, Inc. /De/ (HRTX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Adam Morgan

Adam Morgan is recorded as Chairman and Board Member at Heron Therapeutics, Inc. /De/ (HRTX). Heron Therapeutics, Inc. /De/ reported in an 8-K filed June 18, 2024 that Adam Morgan was appointed Director, effective June 13, 2024. Heron Therapeutics, Inc. /De/ reported in an 8-K filed April 3, 2023 that Adam Morgan was appointed Chairman of the Board, effective April 3, 2023. Heron Therapeutics, Inc. /De/ reported in an 8-K filed February 22, 2023 that Adam Morgan was appointed director, effective February 21, 2023.

“to elect six director nominees: Craig Collard, Sharmila Dissanaike, M.D., FACS, FCCM, Craig Johnson, Susan Rodriguez, Christian Waage, and Adam Morgan, to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified”
Heron Therapeutics, Inc. /De/ Form 8-K, filed June 18, 2024 · Read the filing
“the Board has appointed current director Adam Morgan to serve as Chairman of the Board, effective as of the Effective Date.”
Heron Therapeutics, Inc. /De/ Form 8-K, filed April 3, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Heron Therapeutics, Inc. /De/

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.